Aktive Positionen von Alan Tyndall
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| University of Basel | Corporate Officer/Principal | 01.01.1991 | - |
| World Scleroderma Foundation | Unternehmenssekretär | - | - |
| Iterata AG | Direktor/Vorstandsmitglied | - | - |
| Gründer | - | - |
Karriereverlauf von Alan Tyndall
Ehemalige bekannte Positionen von Alan Tyndall
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| MAGENTA THERAPEUTICS | Gründer | 17.06.2015 | - |
Ausbildung von Alan Tyndall
| The University of Sydney | Undergraduate Degree |
Statistik
International
| Schweiz | 4 |
| Vereinigte Staaten | 2 |
| Japan | 2 |
Operativ
| Founder | 2 |
| Corporate Officer/Principal | 1 |
| Corporate Secretary | 1 |
Sektoral
| Consumer Services | 3 |
| Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
Magenta Therapeutics, Inc.
 Magenta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Magenta Therapeutics, Inc. is a biotechnology company, which focuses on improving stem cell transplantation. Its platform includes MGTA-117, MGTA-145, and CD45-ADC. The company was founded by David T. Scadden, Derrick J. Rossi, Alan Tyndall, Luigi Naldini, Robert Negrin, John F. Dipersio, and Jason Gardner on June 17, 2015 and is headquartered in Cambridge, MA. | Health Technology |
| World Scleroderma Foundation | |
| Iterata AG |
- Börse
- Insiders
- Alan Tyndall
- Erfahrung
